INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Handelsbanken Fonder AB's Holding History (CIK: 0001398318)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 29,300 Value ($000) $4 Avg Close Range
Q4 2024
Shares 27,100 Value ($000) $2 Avg Close Range
Q3 2024
Shares 26,300 Value ($000) $2 Avg Close Range
Q2 2024
Shares 21,300 Value ($000) $1 Avg Close Range
Q1 2024
Shares 18,500 Value ($000) $1 Avg Close Range
Q4 2023
Shares 18,500 Value ($000) $1 Avg Close Range
Q3 2023
Shares 17,400 Value ($000) $1 Avg Close Range
Q2 2023
Shares 15,400 Value ($000) $1 Avg Close Range
Q1 2023
Shares 11,800 Value ($000) $1 Avg Close Range
Q4 2022
Shares 11,800 Value ($000) $1 Avg Close Range
Q3 2022
Shares 11,800 Value ($000) $549 Avg Close Range
Q2 2022
Shares 11,800 Value ($000) $674 Avg Close Range
Q1 2022
Shares 11,800 Value ($000) $722 Avg Close Range
Q4 2021
Shares 15,400 Value ($000) $806 Avg Close Range
Q3 2021
Shares 15,400 Value ($000) $574 Avg Close Range
Q2 2021
Shares 15,400 Value ($000) $629 Avg Close Range
Q1 2021
Shares 11,400 Value ($000) $387 Avg Close Range
Q4 2020
Shares 11,400 Value ($000) $363 Avg Close Range
Q3 2020
Shares 11,400 Value ($000) $293 Avg Close Range
Q2 2020
Shares 11,400 Value ($000) $293 Avg Close Range